Table 2. Association of any medical training of person in charge of a patent and proprietary medicine shop with current stock and registration, 16 states in Nigeria, 2013–2014.
| Outcome | No. (%) of people in charge of shop with any medical training |
Likelihood of outcome associated with medical training, OR (95% CI)a |
|||
|---|---|---|---|---|---|
| Yes | No | Bivariate analysis | Multivariate analysisb | ||
| Product stocked | |||||
| Any artemisinin-based combination therapy | 6 513 (38.4) | 10 453 (61.6) | 2.97 (2.71–3.25) | 1.57 (1.39–1.76) | |
| Oral rehydration salts | 6 681 (37.8) | 10 981 (62.2) | 1.47 (1.32–1.62) | 1.16 (1.01–1.32) | |
| Zinc | 1 572 (42.8) | 2 099 (57.2) | 1.34 (1.26–1.43) | 1.12 (1.03–1.23) | |
| Any oral contraceptive | 5 048 (36.2) | 8 893 (63.8) | 1.24 (1.17–1.31) | 0.95 (0.89–1.02) | |
| Injectable contraceptive | 2 261 (50.6) | 2 208 (49.4) | 2.36 (2.21–2.52) | 1.37 (1.28–1.48) | |
| Emergency contraception | 1 701 (32.7) | 3 507 (67.) | 0.89 (0.84–0.95) | 1.06 (0.99–1.14) | |
| Intrauterine contraceptive device | 304 (53.7) | 262 (46.3) | 2.00 (1.64–2.44) | 2.07 (1.71–2.50) | |
| Registration | |||||
| National Association of Patent and Proprietary Medicine Dealers | 5 506 (35.3) | 10 113 (64.7) | 0.65 (0.61–0.70) | 0.87 (0.79–0.95) | |
| Pharmacist Council of Nigeria | 1 137 (44.3) | 1 428 (55.7) | 1.41 (1.32–1.52) | 1.50 (1.34–1.67) | |
CI: confidence interval; OR: odds ratio.
a ORs were estimated using logistic regression. Standard errors for generating confidence intervals were estimated using bootstrap methods with 100 repetitions. Reference category is person without medical training in charge of the patent and proprietary medicine shop.
b The multivariate analysis controlled for the state in which the shop was located, the estimated number of customers per day, urban or rural location and the number of staff members.